A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Emphysema or COPD
- Emphysema
- COPD
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Pulmair Medical, Inc.
- Last updated on ClinicalTrials.gov
- October 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- University of California, San Francisco · San Francisco, CA
Illinois · 1
- Northwestern University · Chicago, IL
Massachusetts · 1
- Beth Israel Deaconess Medical Center · Boston, MA
Wisconsin · 1
- Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.